While preliminary tests found low levels of the nitrosamine impurity N-nitrosodimethylamine (NDMA) in some ranitidine products, the FDA said this does not mean patients taking the drugs should stop using them now.
from WebMD Health https://www.webmd.com/heartburn-gerd/news/20190913/zantac-heartburn-drug-may-contain-carcinogen?src=RSS_PUBLIC
0 Comments:
Post a Comment